About trinity biotech - TRIB
Trinity Biotech Plc engages in the development, manufacture, and marketing of medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market. It operates through the Americas and Rest of World-Ireland geographical segments. The company was founded by Ronan O'Caoimh and Denis R. Burger in June 1992 and is headquartered in Bray, Ireland.
TRIB At a Glance
Trinity Biotech Plc
IDA Business Park
Bray, Wicklow 10
| Phone | 353-1-276-9800 | Revenue | 43.92M | |
| Industry | Medical Specialties | Net Income | -37,491,648.94 | |
| Sector | Health Technology | Employees | 287 | |
| Fiscal Year-end | 12 / 2026 | |||
| View SEC Filings |
TRIB Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 0.335 |
| Price to Book Ratio | N/A |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | -17.854 |
| Enterprise Value to Sales | 3.359 |
| Total Debt to Enterprise Value | 0.935 |
TRIB Efficiency
| Revenue/Employee | 153,033.03 |
| Income Per Employee | -130,632.923 |
| Receivables Turnover | 4.272 |
| Total Asset Turnover | 0.421 |
TRIB Liquidity
| Current Ratio | 0.254 |
| Quick Ratio | 0.121 |
| Cash Ratio | 0.036 |
TRIB Profitability
| Gross Margin | 35.405 |
| Operating Margin | -24.945 |
| Pretax Margin | -84.908 |
| Net Margin | -85.363 |
| Return on Assets | -35.971 |
| Return on Equity | N/A |
| Return on Total Capital | -56.805 |
| Return on Invested Capital | -410.283 |
TRIB Capital Structure
| Total Debt to Total Equity | N/A |
| Total Debt to Total Capital | 209.062 |
| Total Debt to Total Assets | 131.206 |
| Long-Term Debt to Equity | N/A |
| Long-Term Debt to Total Capital | 41.166 |